At a glance
ClinicalIndex Comparison RecordN/ACompleted· 13,182 enrolled
Drug / intervention
No specific interventionother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Epidemiology of Cardiovascular Disease, Haematological Abnormalities, and Other Comorbidities in Early Rheumatoid Arthritis in the United Kingdom and Their Associations With Important Outcomes
In Brief
An observational study evaluating No specific intervention for Rheumatoid Arthritis. Completed, enrolled 13,182 participants across 1 site.
Detailed Summary
Identify the burden of comorbidity at the time of diagnosis of rheumatoid arthritis. Identify the impact of comorbidity present at diagnosis on cardiovascular disease, death, rheumatoid arthritis disease progression and infections.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsRheumatoid Arthritis
CountriesUnited Kingdom
Collaborators--
Timeline
N/ACompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartMar 2004
Primary CompletionJan 2017
First PostedSep 2018
TodayJul 2026
First PostedSep 18, 2018
Enrollment StartMar 1, 2004
Primary CompletionJan 1, 2017
TodayJul 2, 2026
Enrollment to primary: 12.8 yearsPosted 7.8 years ago
Interventions
No specific interventionother
Usual care